CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 58 enrolled
Drug / intervention
Spectacles +1 moredevice
Likely dose
Hyperopic spectacle lenses (dose/power not numerically specified)AI-extracted
Key inclusion· 6
  • ✓Age 6-11 years
  • ✓Hyperopia between +1.00D and +4.00D
  • ✓Astigmatism less than 1.00D
  • ✓Anisometropia (difference between eyes) less than 1.00D
Key exclusion· 5
  • ✕Previous wear of glasses or contacts for hyperopia
  • ✕Eye disease affecting visual function
  • ✕Amblyopia (lazy eye)
  • ✕Strabismus (eye turn) or history of strabismus surgery

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00472212
NCT00472212N/ACompleted
CompareCT.gov

Correction of Hyperopia in Children Study

Ohio State University·interventional·Posted May 11, 2007·Updated Apr 18, 2023

In Brief

A clinical study evaluating Spectacles and Control for Hyperopia and Farsightedness. Completed, enrolled 58 participants across 4 sites.

Detailed Summary

The Correction of Hyperopia In Children Study (CHICS) is a placebo-controlled, randomized, masked investigation of the effect of spectacle correction for moderate amounts of hyperopia on visual function, attention, and reading skills in children.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperopia, Farsightedness
CountriesUnited States
CollaboratorsAmerican Academy of Optometry, Transitions, Ohio Lions Eye Research Foundation, College of Optometrists in Vision Development, SUNY Research Foundation

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 11, 2007
Enrollment StartNov 1, 2003
Primary CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 19.1 years ago

Interventions

Spectaclesdevice

Hyperopic spectacle lenses

Controldevice

Plano (no power, control) spectacle lenses